Autosomal dominant osteopetrosis type II (ADO2), also known as Albers-Schonberg disease, is the most common form of osteopetrosis. It is caused by heterozygous mutations in the CLCN7 chloride channel gene, which acts through a dominant negative mechanism since chloride channels function as dimers. The disease has incomplete penetrance (66%) and variable expressivity. Clinical features include increased skeletal density, recurrent fractures, osteomyelitis (particularly mandibular), and cranial nerve complications including visual impairment, hearing loss, and facial palsy. CLCN7 mutations also cause autosomal recessive osteopetrosis when homozygous, establishing ADO2 as allelic with a subset of infantile malignant osteopetrosis.
Ask a research question about Autosomal Dominant Osteopetrosis Type II. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: Autosomal Dominant Osteopetrosis Type II
creation_date: '2026-02-13T00:31:42Z'
updated_date: '2026-05-08T16:21:17Z'
category: Mendelian
description: >
Autosomal dominant osteopetrosis type II (ADO2), also known as Albers-Schonberg
disease, is the most common form of osteopetrosis. It is caused by heterozygous
mutations in the CLCN7 chloride channel gene, which acts through a dominant
negative mechanism since chloride channels function as dimers. The disease has
incomplete penetrance (66%) and variable expressivity. Clinical features include
increased skeletal density, recurrent fractures, osteomyelitis (particularly
mandibular), and cranial nerve complications including visual impairment,
hearing loss, and facial palsy. CLCN7 mutations also cause autosomal recessive
osteopetrosis when homozygous, establishing ADO2 as allelic with a subset of
infantile malignant osteopetrosis.
disease_term:
preferred_term: autosomal dominant osteopetrosis 2
term:
id: MONDO:0008156
label: autosomal dominant osteopetrosis 2
parents:
- Sclerosing Bone Dysplasias
inheritance:
- name: Autosomal Dominant
description: >
Autosomal dominant with incomplete penetrance (66%) and variable expressivity.
Heterozygous CLCN7 mutations exert a dominant negative effect on the chloride
channel dimer. Unaffected gene carriers show increased bone mineral density
without clinical disease.
evidence:
- reference: PMID:12929941
reference_title: "Chloride channel 7 (ClCN7) gene mutations and autosomal dominant osteopetrosis, type II."
supports: SUPPORT
snippet: "disease penetrance was 66% (62 clinically affected individuals/94 subjects with the gene mutation)"
explanation: "Demonstrates incomplete penetrance of 66% in the largest ADO2 cohort."
prevalence:
- population: Autosomal dominant osteopetrosis overall
percentage: 1 in 20,000 births
notes: >-
Exact ADO2-specific prevalence is rarely reported separately. This value is
retained only as background epidemiology for autosomal dominant
osteopetrosis overall and should not be interpreted as an ADO2-specific
prevalence estimate.
evidence:
- reference: PMID:37465191
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Autosomal dominant osteopetrosis has an incidence of 1 in 20,000 newborns and autosomal recessive one has 1 in 250,000."
explanation: Review-level epidemiology provides the standard incidence estimate for autosomal dominant osteopetrosis overall, not specifically for ADO2.
pathophysiology:
- name: CLCN7 Dominant Negative Chloride Channel Dysfunction
description: >
CLCN7 encodes a chloride channel that functions as a homodimer.
Heterozygous missense mutations exert a dominant negative effect by
incorporating mutant subunits into the dimer, impairing chloride
transport. Loss-of-function (null) mutations in heterozygous state
do not cause disease, confirming that the pathogenic mechanism is
dominant negative rather than haploinsufficiency.
cell_types:
- preferred_term: Osteoclast
term:
id: CL:0000092
label: osteoclast
evidence:
- reference: PMID:11741829
reference_title: "Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene."
supports: SUPPORT
snippet: "seven different mutations in the gene encoding the ClCN7 chloride channel in all 12 ADO II families analysed"
explanation: "Identifies CLCN7 as the causative gene for ADO2."
- reference: PMID:11741829
reference_title: "Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene."
supports: SUPPORT
snippet: "ADO II reflects a dominant negative effect, whereas loss-of-function mutations in ClCN7 do not cause abnormalities in heterozygous individuals"
explanation: "Establishes the dominant negative mechanism for CLCN7 missense mutations in ADO2."
- reference: PMID:12929941
reference_title: "Chloride channel 7 (ClCN7) gene mutations and autosomal dominant osteopetrosis, type II."
supports: SUPPORT
snippet: "Based on the preponderance of missense mutations and the knowledge that chloride channels probably function as dimers, it seems that heterozygous ClCN7 gene mutations may cause ADO2 through a dominant negative mechanism"
explanation: "Proposes that dimeric channel structure enables dominant negative pathogenesis."
downstream:
- target: Impaired Resorption Lacuna Acidification
description: >-
Dominant-negative CLCN7 channel dysfunction impairs osteoclast resorption
lacuna acidification.
- name: Impaired Resorption Lacuna Acidification
description: >
Dysfunctional CLCN7 chloride channels reduce the ability of osteoclasts
to acidify the resorption lacuna, decreasing bone resorption capacity.
notes: >-
ADO2 shows incomplete penetrance and variable expressivity, but penetrance
data are epidemiologic context rather than direct evidence for lacuna
acidification.
biological_processes:
- preferred_term: Bone Resorption
term:
id: GO:0045453
label: bone resorption
evidence:
- reference: PMID:11741829
reference_title: "Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene."
supports: SUPPORT
snippet: "the most common form of osteopetrosis, a group of conditions characterized by an increased skeletal mass due to impaired bone and cartilage resorption"
explanation: "Impaired bone resorption leads to the characteristic increased skeletal mass."
downstream:
- target: Progressive Skeletal Sclerosis
description: >-
Reduced osteoclast acidification decreases bone resorption and drives
progressive skeletal sclerosis.
- name: Progressive Skeletal Sclerosis
description: >
Progressive accumulation of unresorbed bone leads to generalized
skeletal sclerosis with paradoxically brittle bones due to disrupted
microarchitecture from impaired remodeling.
biological_processes:
- preferred_term: Bone Remodeling
term:
id: GO:0046849
label: bone remodeling
evidence:
- reference: PMID:11741829
reference_title: "Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene."
supports: SUPPORT
snippet: "the most common form of osteopetrosis, a group of conditions characterized by an increased skeletal mass due to impaired bone and cartilage resorption"
explanation: "Increased skeletal mass results from progressive bone accumulation."
phenotypes:
- name: Osteopetrosis
description: >
Generalized osteosclerosis with increased skeletal density, especially in
the spine and pelvis, is the hallmark radiographic abnormality of ADO2.
Classic radiographs may also show bone-within-bone appearance.
phenotype_term:
preferred_term: Osteopetrosis
term:
id: HP:0011002
label: Osteopetrosis
evidence:
- reference: PMID:11741829
reference_title: "Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene."
supports: SUPPORT
snippet: "the most common form of osteopetrosis, a group of conditions characterized by an increased skeletal mass due to impaired bone and cartilage resorption"
explanation: "Defines ADO2 as the most common osteopetrosis form with increased skeletal mass."
- reference: PMID:10617161
reference_title: "Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients."
supports: SUPPORT
snippet: "Type II autosomal dominant osteopetrosis (ADO II, Albers-Schonberg disease) is a genetic condition characterized by generalized osteosclerosis predominating in some skeletal sites such as the spine and pelvis."
explanation: "Supports generalized osteosclerosis with spine and pelvis predominance as a characteristic ADO2 radiographic phenotype."
- reference: PMID:24260721
reference_title: "Clinical and Radiological Findings of Autosomal Dominant Osteopetrosis Type II: A Case Report."
supports: SUPPORT
snippet: "the radiographs revealed generalised osteosclerosis and hallmark radiographic features of ADO type II, that is, \"bone-within-bone appearance\" and \"Erlenmeyer-flask deformity.\""
explanation: "Adds exact PMID-backed support that bone-within-bone appearance is a hallmark ADO2 radiographic manifestation."
- name: Recurrent Fractures
description: >
Fractures are the most prevalent clinical consequence of ADO2, and severe
fracture patterns are seen only in affected subjects.
frequency: VERY_FREQUENT
phenotype_term:
preferred_term: Recurrent fractures
term:
id: HP:0002757
label: Recurrent fractures
evidence:
- reference: PMID:17164308
reference_title: "Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation."
supports: SUPPORT
snippet: "subjects with ADO had a significantly increased prevalence of fracture (84 vs. 36%; P < 0.0001)"
explanation: "84% fracture prevalence falls in the VERY_FREQUENT band (80-99%)."
- reference: PMID:17164308
reference_title: "Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation."
supports: SUPPORT
snippet: "Severe fractures (defined as > or =10 fractures of any type and/or greater than one hip/femur fracture) were identified only in ADO subjects"
explanation: "Supports that ADO2 can include clinically important severe fracture burden, not just incidental fractures."
- name: Osteomyelitis
description: >
Osteomyelitis is an occasional complication of ADO2 and most often affects
the jaws, particularly the mandible.
frequency: OCCASIONAL
phenotype_term:
preferred_term: Osteomyelitis
term:
id: HP:0002754
label: Osteomyelitis
evidence:
- reference: PMID:17164308
reference_title: "Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation."
supports: SUPPORT
snippet: "subjects with ADO had a significantly increased prevalence of fracture (84 vs. 36%; P < 0.0001) and osteomyelitis (16 vs. 0.9%; P < 0.0001)"
explanation: "16% osteomyelitis prevalence in ADO subjects falls in the OCCASIONAL band (5-29%)."
- reference: PMID:10617161
reference_title: "Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients."
supports: SUPPORT
snippet: "Nearly two-thirds of patients (64%) had stomatologic manifestations, including mandibular osteomyelitis in 4 patients (11%)."
explanation: "Adds disease-specific support for mandibular predilection of osteomyelitis in ADO2."
- name: Visual impairment
description: >
Visual impairment or vision loss is an occasional but clinically important
complication of ADO2.
frequency: OCCASIONAL
phenotype_term:
preferred_term: Visual impairment
term:
id: HP:0000505
label: Visual impairment
evidence:
- reference: PMID:17164308
reference_title: "Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation."
supports: SUPPORT
snippet: "Visual loss, which typically had its onset in childhood, and bone marrow failure occurred in 19 and 3% of ADO subjects, respectively"
explanation: "19% visual loss falls in the OCCASIONAL band (5-29%)."
phenotype_contexts:
- onset:
onset_category: CHILDHOOD
notes: Visual loss was reported as typically beginning in childhood.
evidence:
- reference: PMID:17164308
reference_title: "Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation."
supports: SUPPORT
snippet: "Visual loss, which typically had its onset in childhood, and bone marrow failure occurred in 19 and 3% of ADO subjects, respectively"
explanation: "Directly supports childhood onset of visual impairment in ADO2."
- name: Hearing impairment
description: >
Cranial nerve involvement in ADO2 can include hearing loss, although the
available abstract evidence does not quantify hearing impairment separately
from other cranial neuropathies.
phenotype_term:
preferred_term: Hearing impairment
term:
id: HP:0000365
label: Hearing impairment
evidence:
- reference: PMID:10617161
reference_title: "Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients."
supports: SUPPORT
snippet: "Cranial nerve involvement responsible for hearing loss, bilateral optic atrophy, and/or facial palsy was present in 14 patients but was clearly attributable to ADO II in only 6 cases (16%)."
explanation: "Directly supports hearing loss as part of the ADO2 cranial nerve phenotype, but the abstract does not provide a hearing-specific frequency."
- name: Facial palsy
description: >
Facial palsy is part of the cranial nerve complication spectrum of ADO2.
phenotype_term:
preferred_term: Facial palsy
term:
id: HP:0010628
label: Facial palsy
evidence:
- reference: PMID:10617161
reference_title: "Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients."
supports: SUPPORT
snippet: "Cranial nerve involvement responsible for hearing loss, bilateral optic atrophy, and/or facial palsy was present in 14 patients but was clearly attributable to ADO II in only 6 cases (16%)."
explanation: "Directly supports facial palsy as part of the ADO2 cranial nerve phenotype, but the abstract does not provide a facial-palsy-specific frequency."
- name: Bone marrow failure
description: >
Bone marrow failure is a rare but clinically important hematologic
complication of ADO2.
frequency: VERY_RARE
phenotype_term:
preferred_term: Bone marrow failure
term:
id: HP:0005528
label: Bone marrow hypocellularity
evidence:
- reference: PMID:17164308
reference_title: "Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation."
supports: SUPPORT
snippet: "Visual loss, which typically had its onset in childhood, and bone marrow failure occurred in 19 and 3% of ADO subjects, respectively"
explanation: "Bone marrow failure affected 3% of ADO subjects, which falls in the VERY_RARE band (<5%)."
- name: Osteoarthritis
description: >
Hip-predominant osteoarthritis can complicate ADO2 and may require
arthroplasty.
frequency: OCCASIONAL
phenotype_term:
preferred_term: Osteoarthritis
term:
id: HP:0002758
label: Osteoarthritis
evidence:
- reference: PMID:10617161
reference_title: "Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients."
supports: SUPPORT
snippet: "Hip osteoarthritis developed in 27% of patients and required arthroplasty in 9 of the 16 affected hips."
explanation: "27% falls in the OCCASIONAL band (5-29%) and shows that hip osteoarthritis is a clinically relevant complication."
- name: Scoliosis
description: >
Thoracic or lumbar scoliosis occurs in a minority of patients with ADO2.
frequency: OCCASIONAL
phenotype_term:
preferred_term: Scoliosis
term:
id: HP:0002650
label: Scoliosis
evidence:
- reference: PMID:10617161
reference_title: "Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients."
supports: SUPPORT
snippet: "Twenty-four percent of patients had thoracic or lumbar scoliosis."
explanation: "24% falls in the OCCASIONAL band (5-29%)."
- name: Sandwich appearance of vertebral bodies
description: >
Vertebral endplate thickening producing a sandwich vertebra appearance is a
classic radiographic sign of ADO2.
phenotype_term:
preferred_term: Sandwich vertebrae
term:
id: HP:0004618
label: Sandwich appearance of vertebral bodies
evidence:
- reference: PMID:10617161
reference_title: "Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients."
supports: SUPPORT
snippet: "Our inclusion criterion was presence on radiographs of the spine of vertebral endplate thickening, producing the classic sandwich vertebra appearance."
explanation: "Directly supports sandwich vertebrae as a hallmark radiographic manifestation of ADO2."
- name: Erlenmeyer flask deformity
description: >
Erlenmeyer-flask deformity is part of the hallmark radiographic phenotype of
ADO2.
phenotype_term:
preferred_term: Erlenmeyer flask deformity
term:
id: HP:0004975
label: Erlenmeyer flask deformity of the femurs
evidence:
- reference: PMID:24260721
reference_title: "Clinical and Radiological Findings of Autosomal Dominant Osteopetrosis Type II: A Case Report."
supports: SUPPORT
snippet: "the radiographs revealed generalised osteosclerosis and hallmark radiographic features of ADO type II, that is, \"bone-within-bone appearance\" and \"Erlenmeyer-flask deformity.\""
explanation: "Supports Erlenmeyer-flask deformity as a characteristic ADO2 radiographic finding."
genetic:
- name: CLCN7 Mutations
association: Causative
notes: >
Heterozygous missense mutations in CLCN7 on chromosome 16p13.3.
Predominantly missense mutations consistent with dominant negative
mechanism through dimeric channel disruption. Nine different
mutations identified in 22 of 23 ADO2 families, indicating
minimal genetic heterogeneity. CLCN7 mutations are allelic with
autosomal recessive osteopetrosis when homozygous.
evidence:
- reference: PMID:12929941
reference_title: "Chloride channel 7 (ClCN7) gene mutations and autosomal dominant osteopetrosis, type II."
supports: SUPPORT
snippet: "nine different mutations have been discovered in the ClCN7 gene in 22 of 23 ADO2 families studied"
explanation: "Near-complete genetic homogeneity with CLCN7 mutations in ADO2."
- reference: PMID:11741829
reference_title: "Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene."
supports: SUPPORT
snippet: "ADO II is allelic with a subset of ARO cases"
explanation: "CLCN7 mutations cause both dominant and recessive osteopetrosis depending on zygosity."
- name: CLCN7
gene_term:
preferred_term: CLCN7
term:
id: hgnc:2025
label: CLCN7
association: Pathogenic Variants
evidence:
- reference: CGGV:assertion_23840c1f-9d30-4ccf-9fc0-604a0cb12eb4-2023-12-04T170000.000Z
reference_title: "CLCN7 / autosomal dominant osteopetrosis 2 (Definitive)"
supports: SUPPORT
evidence_source: OTHER
snippet: "CLCN7 | HGNC:2025 | autosomal dominant osteopetrosis 2 | MONDO:0008156 | AD | Definitive"
explanation: ClinGen classifies the CLCN7-autosomal dominant osteopetrosis 2 gene-disease relationship as definitive with autosomal dominant inheritance.
treatments:
- name: Supportive Care
description: >
Supportive management is directed at complications such as fractures,
osteomyelitis, and cranial nerve deficits.
treatment_term:
preferred_term: supportive care
term:
id: MAXO:0000950
label: supportive care
- name: Genetic Counseling
description: >
Genetic counseling for affected families, noting incomplete
penetrance of 66% and variable expressivity.
treatment_term:
preferred_term: genetic counseling
term:
id: MAXO:0000079
label: genetic counseling
references:
- reference: DOI:10.1093/jbmr/zjaf123
title: Fractures are highly correlated with bone density and inversely correlated with bone turnover markers in autosomal dominant osteopetrosis
found_in:
- Autosomal_Dominant_Osteopetrosis_Type_II-deep-research-falcon.md
findings:
- statement: Autosomal dominant osteopetrosis (ADO) is a rare osteosclerotic disorder usually caused by missense variants in the CLCN7 gene, which results in impaired osteoclastic bone resorption.
supporting_text: Autosomal dominant osteopetrosis (ADO) is a rare osteosclerotic disorder usually caused by missense variants in the CLCN7 gene, which results in impaired osteoclastic bone resorption.
evidence:
- reference: DOI:10.1093/jbmr/zjaf123
reference_title: Fractures are highly correlated with bone density and inversely correlated with bone turnover markers in autosomal dominant osteopetrosis
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: Autosomal dominant osteopetrosis (ADO) is a rare osteosclerotic disorder usually caused by missense variants in the CLCN7 gene, which results in impaired osteoclastic bone resorption.
explanation: Deep research cited this publication as relevant literature for Autosomal Dominant Osteopetrosis Type II.
- reference: DOI:10.18699/vjgb-23-46
title: Clinical, genetic aspects and molecular pathogenesis of osteopetrosis
found_in:
- Autosomal_Dominant_Osteopetrosis_Type_II-deep-research-falcon.md
findings:
- statement: Osteopetrosis (“marble bone”, ICD-10-78.2) includes a group of hereditary bone disorders distinguished by clinical variability and genetic heterogeneity.
supporting_text: Osteopetrosis (“marble bone”, ICD-10-78.2) includes a group of hereditary bone disorders distinguished by clinical variability and genetic heterogeneity.
evidence:
- reference: DOI:10.18699/vjgb-23-46
reference_title: Clinical, genetic aspects and molecular pathogenesis of osteopetrosis
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: Osteopetrosis (“marble bone”, ICD-10-78.2) includes a group of hereditary bone disorders distinguished by clinical variability and genetic heterogeneity.
explanation: Deep research cited this publication as relevant literature for Autosomal Dominant Osteopetrosis Type II.
- reference: DOI:10.3389/fendo.2022.819641
title: 'Natural History of Type II Autosomal Dominant Osteopetrosis: A Single Center Retrospective Study'
found_in:
- Autosomal_Dominant_Osteopetrosis_Type_II-deep-research-falcon.md
findings:
- statement: Autosomal dominant osteopetrosis II (ADO II, MIM166600) is a sclerosing bone disorder caused by CLCN7 mutation.
supporting_text: Autosomal dominant osteopetrosis II (ADO II, MIM166600) is a sclerosing bone disorder caused by CLCN7 mutation.
evidence:
- reference: DOI:10.3389/fendo.2022.819641
reference_title: 'Natural History of Type II Autosomal Dominant Osteopetrosis: A Single Center Retrospective Study'
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: Autosomal dominant osteopetrosis II (ADO II, MIM166600) is a sclerosing bone disorder caused by CLCN7 mutation.
explanation: Deep research cited this publication as relevant literature for Autosomal Dominant Osteopetrosis Type II.
- reference: DOI:10.3390/ijms241210412
title: Molecular Mechanisms of Craniofacial and Dental Abnormalities in Osteopetrosis
found_in:
- Autosomal_Dominant_Osteopetrosis_Type_II-deep-research-falcon.md
findings:
- statement: Osteopetrosis is a group of genetic bone disorders characterized by increased bone density and defective bone resorption.
supporting_text: Osteopetrosis is a group of genetic bone disorders characterized by increased bone density and defective bone resorption.
evidence:
- reference: DOI:10.3390/ijms241210412
reference_title: Molecular Mechanisms of Craniofacial and Dental Abnormalities in Osteopetrosis
supports: SUPPORT
evidence_source: OTHER
snippet: Osteopetrosis is a group of genetic bone disorders characterized by increased bone density and defective bone resorption.
explanation: Deep research cited this publication as relevant literature for Autosomal Dominant Osteopetrosis Type II.
Autosomal dominant osteopetrosis type II (ADO2) is a rare high–bone-mass skeletal disorder caused by impaired osteoclast-mediated bone resorption, leading to radiographically dense but mechanically fragile bone with frequent fractures and characteristic imaging findings (e.g., “sandwich vertebrae” and “bone-in-bone”). It is also referred to as Albers–Schönberg disease and is described as the commonest adult form of osteopetrosis (funckbrentanoUnknownyearppelmandikstranm pages 1-3, funckbrentanoUnknownyearppelmandikstranm pages 3-4, kang2019acaseof pages 1-3).
Current understanding (key concept): Osteopetrosis represents a group of disorders in which osteoclast formation/function is impaired, resulting in increased bone mass but compromised bone quality, with downstream complications including fractures, cranial nerve compression, and (less commonly in ADO2) marrow compromise (funckbrentanoUnknownyearppelmandikstranm pages 1-3, nadyrshina2023clinicalgeneticaspects pages 2-3).
This report integrates: - Aggregated resources and expert reviews (2023–2024) (funckbrentanoUnknownyearppelmandikstranm pages 1-3, nadyrshina2023clinicalgeneticaspects pages 1-2, ma2023molecularmechanismsof pages 2-4) - Human cohort / natural history studies (2022; plus a later natural-history biomarker report) (wang2022naturalhistoryof pages 1-2, wang2022naturalhistoryof pages 8-9, econs2026fracturesarehighly pages 1-3) - Case reports (illustrating variable expressivity and reduced penetrance) (kang2019acaseof pages 1-3) - Model organism and mechanistic synthesis (mouse models; craniofacial/dental mechanisms) (ma2023molecularmechanismsof pages 2-4, ma2023molecularmechanismsof pages 8-10)
Primary cause: germline heterozygous pathogenic variants in CLCN7 (Cl−/H+ antiporter 7; historically described as a “chloride channel”), causing osteoclast dysfunction with impaired resorption lacuna acidification (wang2022naturalhistoryof pages 1-2, funckbrentanoUnknownyearppelmandikstranm pages 1-3, funckbrentanoUnknownyearppelmandikstranm pages 3-4). A 2024 adult osteopetrosis review notes that “more than 34 CLCN7 mutations have been reported” in ADO (funckbrentanoUnknownyearppelmandikstranm pages 1-3).
Key mechanistic etiologic statement (quoted): “Mutation in CLCN7 may disrupt acidification of the osteoclast resorption lacunae, resulting in impaired bone degradation” (ADO II, MIM166600) (wang2022naturalhistoryof pages 1-2).
Additional required component: The OSTM1 subunit is described as required for ClC-7/CLCN7 trafficking to the osteoclast ruffled border (funckbrentanoUnknownyearppelmandikstranm pages 1-3, funckbrentanoUnknownyearppelmandikstranm pages 3-4).
No genetic or environmental protective factors were identified in the retrieved evidence.
No specific gene–environment interactions were identified in the retrieved evidence.
Skeletal fragility/fracture (symptom/sign): - Fracture is a defining complication despite very high BMD (funckbrentanoUnknownyearppelmandikstranm pages 3-4, wang2022naturalhistoryof pages 8-9). - In a Chinese cohort (n=36), fracture frequency was 55.6% (20/36) (wang2022naturalhistoryof pages 8-9). - A 2024 review summarizes fractures in ~46% of patients and notes delayed healing (funckbrentanoUnknownyearppelmandikstranm pages 3-4). - Fracture risk is not reliably predicted by BMD in at least one follow-up subset: BMD stable over ~6 years, yet 5/15 sustained new fractures (funckbrentanoUnknownyearppelmandikstranm pages 3-4, wang2022naturalhistoryof pages 5-6).
Delayed fracture healing (clinical course): - Fractures may show delayed consolidation, sometimes “months to years” per adult osteopetrosis review (funckbrentanoUnknownyearppelmandikstranm pages 3-4).
Osteomyelitis (especially mandibular) / dental infection: - Mandibular osteomyelitis is highlighted as a difficult complication requiring prolonged treatment (funckbrentanoUnknownyearppelmandikstranma pages 4-5).
Cranial nerve compression / skull-base complications: - Vision loss, hearing loss, and facial palsy can occur from skull base sclerosis and foraminal narrowing (wang2022naturalhistoryof pages 8-9, funckbrentanoUnknownyearppelmandikstranma pages 4-5, nadyrshina2023clinicalgeneticaspects pages 2-3). - In the Chinese cohort, visual loss was 1/36 and bone marrow failure 2/36 (wang2022naturalhistoryof pages 1-2).
Degenerative joint disease / hip osteoarthritis: - Hip osteoarthritis and joint discomfort are reported clinical characteristics (wang2022naturalhistoryof pages 1-2, wang2022naturalhistoryof pages 5-6).
Hematologic features (less common in ADO2): - Reduced marrow space can contribute to anemia/hepatosplenomegaly in osteopetrosis broadly; adult ADO2 marrow failure is noted as uncommon but possible (funckbrentanoUnknownyearppelmandikstranm pages 3-4, nadyrshina2023clinicalgeneticaspects pages 2-3).
A 2023 craniofacial/dental review explicitly catalogs craniofacial and dental abnormalities across osteopetrosis subtypes and includes ADO2/OPTA2 (OMIM #166600). It emphasizes that ion channels/transporters including TCIRG1, CLCN7, OSTM1, SLC4A2 “may control osteoclastic acidification” (ma2023molecularmechanismsof pages 1-2). It also recommends dental attention to prevent missed diagnoses: “It is recommended that dentists pay attention to the craniofacial condition of osteopetrosis patients to reduce missed diagnoses” (ma2023molecularmechanismsof pages 12-13).
(IDs should be verified against current HPO release during KB ingestion.) - Increased bone mineral density / osteosclerosis (e.g., Osteosclerosis) - Pathologic fracture / recurrent fractures - Delayed fracture healing - Osteomyelitis of the jaw / mandibular osteomyelitis - Visual impairment / optic atrophy (optic canal narrowing mechanism noted) (wang2022naturalhistoryof pages 8-9) - Hearing impairment - Facial palsy - Dental anomalies: delayed tooth eruption, hypodontia/dental agenesis, caries, malocclusion (funckbrentanoUnknownyearppelmandikstranma pages 4-5, ma2023molecularmechanismsof pages 8-10)
Direct QoL instrument data (e.g., SF-36, PROMIS) were not present in the retrieved evidence set; however, fracture burden, chronic osteomyelitis, and sensory impairment are expected to be major drivers of disability (funckbrentanoUnknownyearppelmandikstranm pages 1-3, funckbrentanoUnknownyearppelmandikstranm pages 3-4).
Variant spectrum and frequencies (cohort-level): In a single-center Chinese cohort (n=36), 21 disease-causing CLCN7 mutations were detected (wang2022naturalhistoryof pages 5-6). - c.2299C>T (p.Arg767Trp): 16.2% - c.296A>G (p.Tyr99Cys): 10.8% - c.857G>A (p.Arg286Gln): 10.8% - c.937G>A (p.Glu313Lys): 8.1% (wang2022naturalhistoryof pages 5-6, wang2022naturalhistoryof pages 8-9)
Reported genotype–phenotype link (example): c.937G>A (p.Glu313Lys) was associated with “severe fractures, haematological defects and cranial palsy” in this cohort (wang2022naturalhistoryof pages 1-2).
Penetrance / expressivity: - Incomplete penetrance (~66% symptomatic carriers) (funckbrentanoUnknownyearppelmandikstranm pages 3-4, funckbrentanoUnknownyearppelmandikstranm pages 1-3) - Penetrance estimate 69.23% in one cohort (wang2022naturalhistoryof pages 2-3) - Familial penetrance reported range 60–90% in a case report review (kang2019acaseof pages 1-3)
Expert interpretation: A later natural-history biomarker study emphasizes marked intrafamilial variability and reports no significant phenotype differences between the most common variant in that cohort (G215R) vs other variants across fracture/BMD/biochemical markers (econs2026fracturesarehighly pages 1-3).
No validated modifier genes or protective variants specific to ADO2 were identified in the retrieved evidence.
Not identified for ADO2 in the retrieved evidence.
No disease-specific environmental, lifestyle, or infectious triggers were identified in the retrieved evidence set. Clinical risks in ADO2 are primarily genetically determined.
A 2023 craniofacial/dental mechanisms review describes core acidification machinery: CA2 generates H+; V-ATPase pumps H+; CLCN7/OSTM1 functions as a 2Cl−/H+ antiporter contributing to acidification and resorption processes; SLC4A2 supports Cl− flux and downstream protease activation and cytoskeletal/podosome dynamics (ma2023molecularmechanismsof pages 8-10).
Demographics: A Chinese cohort reports fractures often occurring at ≤18 years among those who fracture (age distribution for fractures presented as “≤18/>18: 37/7”) (wang2022naturalhistoryof pages 8-9). Sex ratio and geographic/ancestry enrichment were not available in the retrieved evidence.
Radiographic hallmarks (diagnostic cornerstone): - “Sandwich vertebrae”/vertebral endplate sclerosis; “bone-in-bone” appearances; skull base densification; Erlenmeyer-flask changes (funckbrentanoUnknownyearppelmandikstranm pages 3-4, funckbrentanoUnknownyearppelmandikstranma pages 4-5).
Imaging for complications: MRI/CT/tomodensitometry to monitor optic foramina and cranial nerve compression (funckbrentanoUnknownyearppelmandikstranm pages 3-4).
DXA typically shows markedly increased BMD (e.g., Z-score > +2), but BMD may not reliably predict fracture risk and routine serial BMD is not recommended for fracture-risk monitoring by one expert review (funckbrentanoUnknownyearppelmandikstranm pages 3-4).
A cohort states: “The diagnosis of ADOII depends on clinical manifestations, typical imaging examinations and CLCN7 gene mutation” (wang2022naturalhistoryof pages 2-3). Practical approach: targeted CLCN7 testing or broader skeletal dysplasia/osteoclast disorder panels or exome sequencing depending on context.
Not comprehensively captured in retrieved evidence; key clinical differentials include other osteosclerotic disorders and other osteopetrosis genetic subtypes (e.g., LRP5-driven OPTA1; recessive TCIRG1/OSTM1 forms), which differ in severity, hematologic involvement, and transplant responsiveness (nadyrshina2023clinicalgeneticaspects pages 2-3, ma2023molecularmechanismsof pages 12-13).
Quantitative survival/life expectancy statistics specific to ADO2 were not available in the retrieved evidence set.
Consensus from adult osteopetrosis expert review: Adult ADO2 care is largely supportive and multidisciplinary, ideally in specialized centers, focusing on monitoring and managing fractures, dental/mandibular infections, and cranial nerve complications (funckbrentanoUnknownyearppelmandikstranm pages 1-3, funckbrentanoUnknownyearppelmandikstranma pages 4-5).
Examples of real-world management needs: - Mandibular osteomyelitis may require “long-term antibiotic therapy and surgical debridement” (funckbrentanoUnknownyearppelmandikstranma pages 4-5). - Skull base/cranial foramina involvement may require specialized ophthalmologic/ENT monitoring and, in some cases, surgical decompression or neurosurgical intervention (funckbrentanoUnknownyearppelmandikstranma pages 4-5).
A 2023 review notes HSCT “is recognized as the most effective treatment, which allows restoration of bone resorption by cells of donor origin,” but also emphasizes genotype-specific contraindications (e.g., severe neurological disorders in TNFSF11/OSTM1) (nadyrshina2023clinicalgeneticaspects pages 2-3). Adult ADO2 (CLCN7) is generally managed conservatively rather than transplanted in the reviewed expert summary (funckbrentanoUnknownyearppelmandikstranm pages 1-3).
Expert reviews emphasize knowledge gaps and the need for therapies that restore osteoclast resorptive capacity and for better natural history/endpoint development (funckbrentanoUnknownyearppelmandikstranm pages 1-3, econs2026fracturesarehighly pages 1-3).
No primary prevention exists for a Mendelian causal disorder; practical prevention is tertiary prevention of complications via surveillance and prompt management: - Prevent/manage dental infection and avoid high-risk dental trauma when possible; early referral for mandibular infection (funckbrentanoUnknownyearppelmandikstranma pages 4-5, ma2023molecularmechanismsof pages 12-13) - Monitor for cranial nerve compromise (vision/hearing) (funckbrentanoUnknownyearppelmandikstranma pages 4-5) - Genetic counseling for affected families due to AD inheritance and incomplete penetrance (kang2019acaseof pages 1-3)
No naturally occurring veterinary ADO2 analogs were identified in the retrieved evidence set.
The following table consolidates incidence, penetrance, fracture burden, and recurrent CLCN7 variant frequencies and phenotype notes.
| Finding | Value | Population/Study | Year | PMID/DOI/URL | Evidence ID |
|---|---|---|---|---|---|
| Estimated incidence of ADO/ADO2 | ~1 in 20,000 births | Adult osteopetrosis review; ADO2/Albers–Schönberg disease described as the common adult form | 2024 | Eur J Med Genet review URL not fully available in context; OpenTargets disease mapping available: https://platform.opentargets.org/disease/MONDO_0008156 | (funckbrentanoUnknownyearppelmandikstranm pages 1-3, OpenTargets Search: autosomal dominant osteopetrosis type II,Albers-Schönberg disease-CLCN7) |
| Penetrance of CLCN7-associated ADO2 | ~66% symptomatic carriers | Review summary of mutation carriers with incomplete penetrance | 2024 | Review URL not fully available in context | (funckbrentanoUnknownyearppelmandikstranm pages 3-4, funckbrentanoUnknownyearppelmandikstranm pages 1-3) |
| Penetrance in single-center Chinese cohort | 69.23% | 36 patients from 28 unrelated families with ADOII | 2022 | DOI: 10.3389/fendo.2022.819641; https://doi.org/10.3389/fendo.2022.819641 | (wang2022naturalhistoryof pages 2-3) |
| Penetrance range reported in families | 60–90% | Family/case-based literature summarized in Korean case report | 2019 | DOI: 10.4274/jcrpe.galenos.2019.2018.0229; https://doi.org/10.4274/jcrpe.galenos.2019.2018.0229 | (kang2019acaseof pages 1-3) |
| Overall fracture frequency in ADO2 | ~46% | Review summary of ADO2 patients | 2024 | Review URL not fully available in context | (funckbrentanoUnknownyearppelmandikstranm pages 3-4, funckbrentanoUnknownyearppelmandikstranma pages 3-4) |
| Fracture frequency in Chinese ADO2 cohort | 55.6% (20/36) | 36 Chinese patients with ADO II | 2022 | DOI: 10.3389/fendo.2022.819641; https://doi.org/10.3389/fendo.2022.819641 | (wang2022naturalhistoryof pages 8-9) |
| Fracture frequency by age group in prior series | 53% affected children; 98% affected adults | Prior ADO cohort summarized in natural-history/biomarker study | 2026 | DOI: 10.1093/jbmr/zjaf123; https://doi.org/10.1093/jbmr/zjaf123 | (econs2026fracturesarehighly pages 8-10) |
| Severe fractures by age group in prior series | 16% children; 49% adults | Prior ADO cohort summarized in natural-history/biomarker study | 2026 | DOI: 10.1093/jbmr/zjaf123; https://doi.org/10.1093/jbmr/zjaf123 | (econs2026fracturesarehighly pages 8-10) |
| Fracture frequency in Benichou series | 78% | 42 ADO patients summarized in biomarker study | 2026 | DOI: 10.1093/jbmr/zjaf123; https://doi.org/10.1093/jbmr/zjaf123 | (econs2026fracturesarehighly pages 8-10) |
| Visual loss frequency in Chinese ADO2 cohort | 1/36 (2.8%) | 36 Chinese patients with ADO II | 2022 | DOI: 10.3389/fendo.2022.819641; https://doi.org/10.3389/fendo.2022.819641 | (wang2022naturalhistoryof pages 1-2) |
| Bone marrow failure frequency in Chinese ADO2 cohort | 2/36 (5.6%) | 36 Chinese patients with ADO II | 2022 | DOI: 10.3389/fendo.2022.819641; https://doi.org/10.3389/fendo.2022.819641 | (wang2022naturalhistoryof pages 1-2) |
| Key retrospective cohort size | 36 patients; 28 unrelated families | Single-center ADO II natural history study | 2022 | DOI: 10.3389/fendo.2022.819641; https://doi.org/10.3389/fendo.2022.819641 | (wang2022naturalhistoryof pages 2-3) |
| Longitudinal follow-up subset | 15 patients; mean follow-up 6.3 years (range 1–14 years) | Subset of the Chinese ADO II cohort | 2022 | DOI: 10.3389/fendo.2022.819641; https://doi.org/10.3389/fendo.2022.819641 | (wang2022naturalhistoryof pages 1-2, wang2022naturalhistoryof pages 5-6) |
| New fractures during follow-up | 5/15 | Followed patients in Chinese ADO II cohort | 2022 | DOI: 10.3389/fendo.2022.819641; https://doi.org/10.3389/fendo.2022.819641 | (wang2022naturalhistoryof pages 5-6) |
| Baseline natural-history/biomarker cohort size | 54 total (42 adults, 12 children); 37 adults with disease-causing CLCN7 variants | Cross-sectional baseline analysis in ADO natural history study | 2026 | DOI: 10.1093/jbmr/zjaf123; https://doi.org/10.1093/jbmr/zjaf123 | (econs2026fracturesarehighly pages 1-3) |
| Number of disease-causing CLCN7 mutations identified | 21 mutations | 36 Chinese ADO II patients | 2022 | DOI: 10.3389/fendo.2022.819641; https://doi.org/10.3389/fendo.2022.819641 | (wang2022naturalhistoryof pages 5-6, wang2022naturalhistoryof pages 1-2) |
| Reported number of CLCN7 mutations in ADO overall | >34 mutations reported | Review summary | 2024 | Review URL not fully available in context | (funckbrentanoUnknownyearppelmandikstranm pages 1-3) |
| Most frequent CLCN7 variant | c.2299C>T (p.Arg767Trp), 16.2% (6 cases) | Chinese ADO II cohort | 2022 | DOI: 10.3389/fendo.2022.819641; https://doi.org/10.3389/fendo.2022.819641 | (wang2022naturalhistoryof pages 5-6, wang2022naturalhistoryof pages 8-9, wang2022naturalhistoryof pages 1-2) |
| Phenotype of c.2299C>T (p.Arg767Trp) | Joint discomfort/osteoarthritis common; 4/6 fractured, including 1 multiple fractures | Chinese ADO II cohort | 2022 | DOI: 10.3389/fendo.2022.819641; https://doi.org/10.3389/fendo.2022.819641 | (wang2022naturalhistoryof pages 5-6) |
| Second recurrent CLCN7 variant | c.296A>G (p.Tyr99Cys), 10.8% (4 cases) | Chinese ADO II cohort | 2022 | DOI: 10.3389/fendo.2022.819641; https://doi.org/10.3389/fendo.2022.819641 | (wang2022naturalhistoryof pages 5-6, wang2022naturalhistoryof pages 8-9) |
| Phenotype of c.296A>G (p.Tyr99Cys) | Fractures in 2 patients | Chinese ADO II cohort | 2022 | DOI: 10.3389/fendo.2022.819641; https://doi.org/10.3389/fendo.2022.819641 | (wang2022naturalhistoryof pages 5-6) |
| Third recurrent CLCN7 variant | c.857G>A (p.Arg286Gln), 10.8% (4 cases) | Chinese ADO II cohort | 2022 | DOI: 10.3389/fendo.2022.819641; https://doi.org/10.3389/fendo.2022.819641 | (wang2022naturalhistoryof pages 5-6, wang2022naturalhistoryof pages 8-9) |
| Phenotype of c.857G>A (p.Arg286Gln) | Mild symptoms; fewer fractures and lower FN/TH BMD Z-scores than p.Arg767Trp group | Chinese ADO II cohort | 2022 | DOI: 10.3389/fendo.2022.819641; https://doi.org/10.3389/fendo.2022.819641 | (wang2022naturalhistoryof pages 5-6, wang2022naturalhistoryof pages 8-9) |
| Fourth recurrent CLCN7 variant | c.937G>A (p.Glu313Lys), 8.1% (3 cases) | Chinese ADO II cohort | 2022 | DOI: 10.3389/fendo.2022.819641; https://doi.org/10.3389/fendo.2022.819641 | (wang2022naturalhistoryof pages 5-6, wang2022naturalhistoryof pages 8-9, wang2022naturalhistoryof pages 1-2) |
| Phenotype of c.937G>A (p.Glu313Lys) | Severe phenotype: severe fractures, visual loss, hematological defects, cranial palsy | Chinese ADO II cohort | 2022 | DOI: 10.3389/fendo.2022.819641; https://doi.org/10.3389/fendo.2022.819641 | (wang2022naturalhistoryof pages 5-6, wang2022naturalhistoryof pages 1-2) |
| Common variant in 2026 registry/natural-history cohort | G215R most common (N=14 among CLCN7 variant carriers analyzed) | Adult ADO natural-history/biomarker cohort | 2026 | DOI: 10.1093/jbmr/zjaf123; https://doi.org/10.1093/jbmr/zjaf123 | (econs2026fracturesarehighly pages 8-10, econs2026fracturesarehighly pages 1-3) |
| Genotype–phenotype conclusion for G215R | No significant difference vs other CLCN7 variants for fracture, BMD, or bone turnover markers | Adult ADO natural-history/biomarker cohort | 2026 | DOI: 10.1093/jbmr/zjaf123; https://doi.org/10.1093/jbmr/zjaf123 | (econs2026fracturesarehighly pages 1-3) |
Table: This table compiles key quantitative data for autosomal dominant osteopetrosis type II, including incidence, penetrance, fracture burden, cohort sizes, and recurrent CLCN7 variants with associated phenotypes. It is useful as a quick evidence map for disease characterization and genotype-phenotype interpretation.
The ADO2 natural history cohort paper includes radiographic examples (sandwich vertebrae; bone-in-bone) and tables summarizing CLCN7 variants and their associated clinical/biochemical features (wang2022naturalhistoryof media 01f471f9, wang2022naturalhistoryof media 1e172433, wang2022naturalhistoryof media 154a27d0).
References
(OpenTargets Search: autosomal dominant osteopetrosis type II,Albers-Schönberg disease-CLCN7): Open Targets Query (autosomal dominant osteopetrosis type II,Albers-Schönberg disease-CLCN7, 6 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.
(funckbrentanoUnknownyearppelmandikstranm pages 1-3): T Funck-Brentano and MC Zillikens. Ppelman-di kstra, nm, & cohen-solal, m.(2024). Unknown journal, Unknown year.
(funckbrentanoUnknownyearppelmandikstranm pages 3-4): T Funck-Brentano and MC Zillikens. Ppelman-di kstra, nm, & cohen-solal, m.(2024). Unknown journal, Unknown year.
(kang2019acaseof pages 1-3): Sol Kang, Young Kyung Kang, Jun Ah Lee, Dong Ho Kim, and Jung Sub Lim. A case of autosomal dominant osteopetrosis type 2 with a <i>clcn7</i> gene mutation. Journal of Clinical Research in Pediatric Endocrinology, 11:439-443, Dec 2019. URL: https://doi.org/10.4274/jcrpe.galenos.2019.2018.0229, doi:10.4274/jcrpe.galenos.2019.2018.0229. This article has 8 citations.
(nadyrshina2023clinicalgeneticaspects pages 2-3): D. D. Nadyrshina and R. I. Khusainova. Clinical, genetic aspects and molecular pathogenesis of osteopetrosis. Vavilov Journal of Genetics and Breeding, 27:383-392, Jul 2023. URL: https://doi.org/10.18699/vjgb-23-46, doi:10.18699/vjgb-23-46. This article has 13 citations.
(wang2022naturalhistoryof pages 1-2): Ziyuan Wang, Xiang Li, Ya Wang, Wenzhen Fu, Yujuan Liu, Zhenlin Zhang, and Chun Wang. Natural history of type ii autosomal dominant osteopetrosis: a single center retrospective study. Frontiers in Endocrinology, Mar 2022. URL: https://doi.org/10.3389/fendo.2022.819641, doi:10.3389/fendo.2022.819641. This article has 13 citations.
(nadyrshina2023clinicalgeneticaspects pages 1-2): D. D. Nadyrshina and R. I. Khusainova. Clinical, genetic aspects and molecular pathogenesis of osteopetrosis. Vavilov Journal of Genetics and Breeding, 27:383-392, Jul 2023. URL: https://doi.org/10.18699/vjgb-23-46, doi:10.18699/vjgb-23-46. This article has 13 citations.
(ma2023molecularmechanismsof pages 2-4): Yu Ma, Yali Xu, Yanli Zhang, and Xiaohong Duan. Molecular mechanisms of craniofacial and dental abnormalities in osteopetrosis. International Journal of Molecular Sciences, 24:10412, Jun 2023. URL: https://doi.org/10.3390/ijms241210412, doi:10.3390/ijms241210412. This article has 21 citations.
(wang2022naturalhistoryof pages 8-9): Ziyuan Wang, Xiang Li, Ya Wang, Wenzhen Fu, Yujuan Liu, Zhenlin Zhang, and Chun Wang. Natural history of type ii autosomal dominant osteopetrosis: a single center retrospective study. Frontiers in Endocrinology, Mar 2022. URL: https://doi.org/10.3389/fendo.2022.819641, doi:10.3389/fendo.2022.819641. This article has 13 citations.
(econs2026fracturesarehighly pages 1-3): Michael J Econs, Stuart J Warden, Ziyue Liu, Paul J Niziolek, Corinne Parks-Schenck, Netsanet Gebregziabher, Rita L Gerard-O'Riley, Marian Hart, Lynda E Polgreen, and Erik A Imel. Fractures are highly correlated with bone density and inversely correlated with bone turnover markers in autosomal dominant osteopetrosis. Journal of Bone and Mineral Research, 41:150-157, Sep 2026. URL: https://doi.org/10.1093/jbmr/zjaf123, doi:10.1093/jbmr/zjaf123. This article has 0 citations and is from a highest quality peer-reviewed journal.
(ma2023molecularmechanismsof pages 8-10): Yu Ma, Yali Xu, Yanli Zhang, and Xiaohong Duan. Molecular mechanisms of craniofacial and dental abnormalities in osteopetrosis. International Journal of Molecular Sciences, 24:10412, Jun 2023. URL: https://doi.org/10.3390/ijms241210412, doi:10.3390/ijms241210412. This article has 21 citations.
(wang2022naturalhistoryof pages 5-6): Ziyuan Wang, Xiang Li, Ya Wang, Wenzhen Fu, Yujuan Liu, Zhenlin Zhang, and Chun Wang. Natural history of type ii autosomal dominant osteopetrosis: a single center retrospective study. Frontiers in Endocrinology, Mar 2022. URL: https://doi.org/10.3389/fendo.2022.819641, doi:10.3389/fendo.2022.819641. This article has 13 citations.
(funckbrentanoUnknownyearppelmandikstranma pages 4-5): T Funck-Brentano and MC Zillikens. Ppelman-di kstra, nm, & cohen-solal, m.(2024). Unknown journal, Unknown year.
(ma2023molecularmechanismsof pages 1-2): Yu Ma, Yali Xu, Yanli Zhang, and Xiaohong Duan. Molecular mechanisms of craniofacial and dental abnormalities in osteopetrosis. International Journal of Molecular Sciences, 24:10412, Jun 2023. URL: https://doi.org/10.3390/ijms241210412, doi:10.3390/ijms241210412. This article has 21 citations.
(ma2023molecularmechanismsof pages 12-13): Yu Ma, Yali Xu, Yanli Zhang, and Xiaohong Duan. Molecular mechanisms of craniofacial and dental abnormalities in osteopetrosis. International Journal of Molecular Sciences, 24:10412, Jun 2023. URL: https://doi.org/10.3390/ijms241210412, doi:10.3390/ijms241210412. This article has 21 citations.
(wang2022naturalhistoryof pages 2-3): Ziyuan Wang, Xiang Li, Ya Wang, Wenzhen Fu, Yujuan Liu, Zhenlin Zhang, and Chun Wang. Natural history of type ii autosomal dominant osteopetrosis: a single center retrospective study. Frontiers in Endocrinology, Mar 2022. URL: https://doi.org/10.3389/fendo.2022.819641, doi:10.3389/fendo.2022.819641. This article has 13 citations.
(funckbrentanoUnknownyearppelmandikstranm pages 4-5): T Funck-Brentano and MC Zillikens. Ppelman-di kstra, nm, & cohen-solal, m.(2024). Unknown journal, Unknown year.
(basit2026geneticsofosteopetrosis pages 8-9): Sulman Basit and Khalid I. Khoshhal. Genetics of osteopetrosis: molecular insights and clinical implications. Journal of Musculoskeletal Surgery and Research, 10:40-50, Nov 2026. URL: https://doi.org/10.25259/jmsr_357_2025, doi:10.25259/jmsr_357_2025. This article has 0 citations.
(funckbrentanoUnknownyearppelmandikstranma pages 3-4): T Funck-Brentano and MC Zillikens. Ppelman-di kstra, nm, & cohen-solal, m.(2024). Unknown journal, Unknown year.
(econs2026fracturesarehighly pages 8-10): Michael J Econs, Stuart J Warden, Ziyue Liu, Paul J Niziolek, Corinne Parks-Schenck, Netsanet Gebregziabher, Rita L Gerard-O'Riley, Marian Hart, Lynda E Polgreen, and Erik A Imel. Fractures are highly correlated with bone density and inversely correlated with bone turnover markers in autosomal dominant osteopetrosis. Journal of Bone and Mineral Research, 41:150-157, Sep 2026. URL: https://doi.org/10.1093/jbmr/zjaf123, doi:10.1093/jbmr/zjaf123. This article has 0 citations and is from a highest quality peer-reviewed journal.
(wang2022naturalhistoryof media 01f471f9): Ziyuan Wang, Xiang Li, Ya Wang, Wenzhen Fu, Yujuan Liu, Zhenlin Zhang, and Chun Wang. Natural history of type ii autosomal dominant osteopetrosis: a single center retrospective study. Frontiers in Endocrinology, Mar 2022. URL: https://doi.org/10.3389/fendo.2022.819641, doi:10.3389/fendo.2022.819641. This article has 13 citations.
(wang2022naturalhistoryof media 1e172433): Ziyuan Wang, Xiang Li, Ya Wang, Wenzhen Fu, Yujuan Liu, Zhenlin Zhang, and Chun Wang. Natural history of type ii autosomal dominant osteopetrosis: a single center retrospective study. Frontiers in Endocrinology, Mar 2022. URL: https://doi.org/10.3389/fendo.2022.819641, doi:10.3389/fendo.2022.819641. This article has 13 citations.
(wang2022naturalhistoryof media 154a27d0): Ziyuan Wang, Xiang Li, Ya Wang, Wenzhen Fu, Yujuan Liu, Zhenlin Zhang, and Chun Wang. Natural history of type ii autosomal dominant osteopetrosis: a single center retrospective study. Frontiers in Endocrinology, Mar 2022. URL: https://doi.org/10.3389/fendo.2022.819641, doi:10.3389/fendo.2022.819641. This article has 13 citations.